Ambarish Dash

Since joining Kirkland, Ambarish’s experience has included advising:

• Thoma Bravo on the £3.1 billion recommended cash offer for Sophos
• Atnahs Pharma on the acquisition of established hypertension medicines from AztraZeneca
• Triton Partners on the financing of its acquisition of Atnahs Pharma
• Altor Equity Partners and its portfolio company CTEK in connection with the refinancing of CTEK’s existing financing arrangements
• Lion Capital on the financing aspects of its acquisition of Crafts Group Limited

Prior to joining Kirkland, Ambarish’s experience includes advising:

• KKR:
  
  • in the financing of its acquisition of Unilever’s spreads business
  • in the financing of its acquisition of TUI’s Travelopia division
  • in connection with GenesisCare’s first European syndicated financing
  • in the financing aspects of its acquisition of Hilding Anders
• Apax Partners:
  
  • in the financing of its acquisition and consolidation of Invent Farma and NuPharm (rebranded Neuraxpharm)
  • in the financing of its acquisition of EVRY; and advising EVRY in its subsequent post-IPO refinancing
  • in the financing of its acquisition of Azelis; and advising Azelis in its subsequent acquisition by EQT
  • in the refinancing of Apax-owned Top Right Group (rebranded Ascential); and advising Ascential in its subsequent post-IPO refinancing
  • in the financing of the acquisition of Solita by the Apax Digital Fund
• Blackstone:
  
  • in the financing of the acquisition of PennWell Corp. by Blackstone-owned Clarion Events
  • in the financing aspects of its acquisition of Ideal Shopping Direct
• Melrose plc in the financing of its public to private acquisition of GKN plc
• Apax Partners, Blackstone and KKR in the financing aspects of various acquisition bids

Simpson Thacher & Bartlett LLP

• Associate (2014–2018)

Allen & Overy LLP

• Associate (2013–2014)
• Trainee Solicitor (2011–2013)